Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Stuart Elborn

Showing results (251-260 of 290) with videos related to

Pageof 29
Sort By:
Annals of the American Thoracic Society|December 22, 2022
Clinimetric Properties of Outcome Measures in BronchiectasisJudy M Bradley, Kathryn Ferguson, Andrew Bailey, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 24, 2018
Antisense oligonucleotide eluforsen improves CFTR function in F508del cystic fibrosisIsabelle Sermet-Gaudelus, John P Clancy, David P Nichols, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 20, 2021
Empire-CF study: A phase 2 clinical trial of leukotriene A4 hydrolase inhibitor acebilustat in adult subjects with cystic fibrosisJ Stuart Elborn, Michael W Konstan, Jennifer L Taylor-Cousar, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 19, 2011
Multicentre trial of weekly risedronate on bone density in adults with cystic fibrosisCharles S Haworth, Linda Sharples, Vikki Hughes, et al.
American Journal of Respiratory Cell and Molecular Biology|April 29, 2022
Cystic Fibrosis Airway Mucus Hyperconcentration Produces a Vicious Cycle of Mucin, Pathogen, and Inflammatory Interactions that Promotes Disease PersistenceBethany D Batson, Bryan T Zorn, Giorgia Radicioni, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 4, 2020
Finding the relevance of antimicrobial stewardship for cystic fibrosisJonathan D Cogen, Barbara C Kahl, Holly Maples, et al.
Chest|October 18, 2017
CORK Study in Cystic Fibrosis: Sustained Improvements in Ultra-Low-Dose Chest CT Scores After CFTR Modulation With IvacaftorNicola J Ronan, Gisli G Einarsson, Maria Twomey, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 29, 2023
Longitudinal changes in the cystic fibrosis airway microbiota with time and treatmentGisli G Einarsson, Laura J Sherrard, Joseph E Hatch, et al.
The Journal of Allergy and Clinical Immunology|May 17, 2017
Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary diseaseAlison J Dicker, Megan L Crichton, Eleanor G Pumphrey, et al.
Respiratory Medicine|December 6, 2024
Airway total bacterial density, microbiota community composition and relationship with clinical parameters in bronchiectasisZina Alfahl, Gisli G Einarsson, J Stuart Elborn, et al.
Pageof 29

Showing results (251-260 of 290) with videos related to

Sort By:
Pageof 29
Annals of the American Thoracic Society|December 22, 2022
Clinimetric Properties of Outcome Measures in BronchiectasisJudy M Bradley, Kathryn Ferguson, Andrew Bailey, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 24, 2018
Antisense oligonucleotide eluforsen improves CFTR function in F508del cystic fibrosisIsabelle Sermet-Gaudelus, John P Clancy, David P Nichols, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 20, 2021
Empire-CF study: A phase 2 clinical trial of leukotriene A4 hydrolase inhibitor acebilustat in adult subjects with cystic fibrosisJ Stuart Elborn, Michael W Konstan, Jennifer L Taylor-Cousar, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 19, 2011
Multicentre trial of weekly risedronate on bone density in adults with cystic fibrosisCharles S Haworth, Linda Sharples, Vikki Hughes, et al.
American Journal of Respiratory Cell and Molecular Biology|April 29, 2022
Cystic Fibrosis Airway Mucus Hyperconcentration Produces a Vicious Cycle of Mucin, Pathogen, and Inflammatory Interactions that Promotes Disease PersistenceBethany D Batson, Bryan T Zorn, Giorgia Radicioni, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 4, 2020
Finding the relevance of antimicrobial stewardship for cystic fibrosisJonathan D Cogen, Barbara C Kahl, Holly Maples, et al.
Chest|October 18, 2017
CORK Study in Cystic Fibrosis: Sustained Improvements in Ultra-Low-Dose Chest CT Scores After CFTR Modulation With IvacaftorNicola J Ronan, Gisli G Einarsson, Maria Twomey, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 29, 2023
Longitudinal changes in the cystic fibrosis airway microbiota with time and treatmentGisli G Einarsson, Laura J Sherrard, Joseph E Hatch, et al.
The Journal of Allergy and Clinical Immunology|May 17, 2017
Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary diseaseAlison J Dicker, Megan L Crichton, Eleanor G Pumphrey, et al.
Respiratory Medicine|December 6, 2024
Airway total bacterial density, microbiota community composition and relationship with clinical parameters in bronchiectasisZina Alfahl, Gisli G Einarsson, J Stuart Elborn, et al.
Pageof 29